Diabetes Drug Seeks Approval for Weight Loss

The drug works by suppressing appetite, making it easier for people to stick to a healthy diet and exercise plan.

Screenshot 2023 04 28 At 3 35 50 Pm
Eli Lilly

According to a recent ABC News article, Eli Lilly’s popular Type 2 diabetes drug Mounjaro could be approved for weight loss by the end of 2023. The drug, marketed under the brand name Wegovy, was originally approved as a diabetes medication but has been found to promote weight loss in clinical trials. It is administered via injection once a week and is designed to help people with obesity lose weight and improve their overall health.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report